Senti Biosciences is trading 9% higher at $0.18 after-hours, following a regular-session close of $0.17; no fresh company-specific catalyst explaining the rebound was identified. - Shares fell 23.92% on October 30 before the after-hours gain. - Recent coverage concerned a director resignation and the October 30 record date for previously announced contingent value rights; neither was connected to this move.